ceo wichmann call year better last take
context expect low head signific flu concern
flu impact bp beyond expect still beat driven
strong bp cost control optum led mco higher ralli
peer prospect improv despit record flu call focus lt growth
shift insur technolog clinic practic justifi increas multipl
wichmann quot call structur shift fragment fee-for-servic
medicin type opportun built believ remain earli
evolut long runway growth see opportun potenti
decad ahead even one complet refer ep grew
stock price compound-annual-growth-rate past decad
season wrong con may well headwind explain
beat/rais bridg primari issu tax model flat
adjust ramp largest step
also factor heavi season intenational busi near break
even profit come given southern hemispher util
trend see grow hdhp mix back end load increment
invest hit sg shift ep mix bp
own hsa bank increasingli critic get underwrit advantag
believ gain hsa market share consum survey indic
util heavili impact hsa balanc hdhp member own
largest hsa bank unit better clariti member hsa balanc
indic slow hsa account growth account growth doubl
digit rang higher aum indic gain share
move group could revenu tailwind lt unit larg account
move retire book group new product run higher revenu dollar
profit see book could transfer creat tailwind revenu growth
take pt view optum competit advantag sustain
despit peer new vc fund drive first mover advantag ai/ml
believ market underestim sustain unit tech far
advanc compar peer item geoloc er divers app
script fill chang physician practic manag solut precheck myscript
chang purchas pattern user see sector transit tech
compani insur arm vs insur thu drive tech multipl
price close april
ep
debt total capit
data protect increas medic cost trend premium price competit
market-lead diversifi health care benefit inform servic compani
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
encourag earli result unh precheck myscript ralli platform
total revenu
certain popul integr care
compani data factset pjc estim
precheck myscript help patient sinc incept last year patient
switch cost effect altern view evid cost save potenti
platform far almost transact date involv precheck myscript
see larg growth opportun ralli doubl membership base nearli
peopl use ralli care per week search use ralli care hospit search
focus tier hospit network provid search redirect patient higher qualiti in-network
option believ earli inning could signific medic cost bender
incent payment hand introduc ralli member
unh/optum team multiplan quest launch blockchain pilot address
unnecessari healthcar spend reconcil error data provid help standard consum
face provid data practic address specialti in-network plan accept new patient colleagu
sean wieland dive deeper topic topic blockchain deep dive
optuminsight continu prove valu opinion new integr elig platform help state
medicaid member access medicaid human servic benefit west virginia becam first state
incorpor new platform almost half state medicaid member access view
great exampl unit valu proposit state drive continu strong medicaid contract win rate
believ put emphasi optumhealth specif optumcar given recent acquisit
better peer ss patient revenu growth sca believ right side consumer
trend patient look lower cost set focus recent urgent care asc
see continu build system time goal market target develop
page
opportun gain share time near term growth opportun nc oh
total revenu
contract updat estim retain revenu ep az contract begin octob
lost revenu new mexico start pa believ receiv posit outcom protest
could result rebid process contract gener revenu ep accord estim
view front runner win ohio mltss delay late north carolina rfp
award date see unh best class technolog capabl medic cost manag driver contract win
nc estim add revenu ep ohio estim contract could gener
revenu ep see well posit given strong report card rate market
share posit abd dual good proxi ltss opinion
estim medicaid market share held small ineffici plan like struggl compet
compani like far superior technolog capabl see trend lead market share gain
time resourc invest technolog need effect manag medic cost trend
medicaid contract win compani
vendor
vendor
vendor
enrol
compani data factset medicaid gov state procur pjc estim
page
total revenu
choos ff
share gain top brand
growth rate annual
vast major unh medicar supplement busi coverag introduct
 reson well consum provid broad good choic senior
remain happi margin profil medicar supplement plan believ collis
medicar supplement plan marketplac help continu drive growth doubl digit
believ market underestim medicar advantag growth believ driven higher
share gain top brand
share gain top brand
pjchc survey kaiser pjc estim
expect growth rate long-term posit tailwind industri leader back
result consum survey peopl found major younger consum respond
age would will trade slightli smaller network less expens health insur
analysi use censu data age distribut combin survey estim impli penetr
realli per year vs consensu belief view posit estim current hold
market membership highest industri believ drive market share gain via
optum analyt platform grow consist provid system everi gain drive increment
ep penetr
page
believ unh increment invest optumventur pay dividend
believ continu make invest optum specif optumcar also continu return capit
sharehold share repurchas guid dividend manag made clear intern
capit deploy mainli direct toward optum improv area technolog suit believ invest
pay evidenc cost trend come lower expect year believ place continu lower
medic cost meanwhil confid keep dividend pay-out ratio consist
believ increas innov statu optumventur incub head former optum ceo
larri renfro increment invest see lead increas invest artifici intellig
machin learn believ optumventur mean new incub encourag increas
focu name former optum ceo depart head invest incub believ invest use
spur forward unh innov includ invest ai machin learn help unh thought lead posit
compani data factset pjc estim
page
believ concern pharmaceut cost overblown
believ concern pharmaceut cost cost trend light year overblown
estim new breakthrough drug come market expens recent approv harvoni fda
approv record number drug trend believ continu believ led increas competit
among drug maker caus lower price believ influx new drug includ gener compet brand drug
least off-set cost new wave cell gene therapi drug come market
view current cost trend guidanc conserv estim unh cost trend come initi
guidanc last quarter found case actual cost trend come lower end initi guidanc
typic lower guidanc bp believ differ given acceler consumer healthcar
compani data factset pjc estim
page
believ unh qualiti display peer high lt ep growth guidanc
compani data factset pjc estim
page
guidanc actualinvestor day actualinvestor day actual growthcurr growthcommercialcommerci risk fee commerci individu advantag supplement medicar enrol ex medicar medicaid health health oper bpsoptum insight insight oper bpsoptumrx oper bpscombin businesstot bpsebit bpstax rais price reflect innov statu
strong oper perform
ep vs consensu estim driven higher expect revenu via optum better
expect estim consensu driven bp y/i decreas due
return hif prior period develop favor impact rel non-materi impact revenu
estim consensu sg bp y/i estim
consensu optum revenu estim optum margin estim
optumhealth revenu estim optuminsight estim optumrx
estim enrol increased/decreas sequenti commerci
estim medicaid in-lin estim medicar estim dcp flat
sequenti day cfo ni repurchas outstand
increas price target reflect increas peer group multipl
price target base ep unchang continu believ deserv
trade premium peer group multipl given unh oper excel innov statu strong growth
prospect unit healthcar optum busi group
compani data factset pjc estim
page
thousand except per share
invest incom
product sold
compani report piper jaffray co current disclosur inform compani found http //www piperjaffray com/researchdisclosur
